Johnson & Johnson

Active …

JNJ.US

Track Add Position News Full Analysis
Company Overview

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through …

Market Cap
658.00B USD
Sector
Healthcare
Industry
Drug Manufacturers - General
Country
USA
Category
Domestic
Currency
USD
Asset Type
Common Stock
Visit Official Website
Price Analysis
Key Metrics

Wall Street Target

$272.50

PE Ratio (TTM)

31.35

Forward PE

23.20

Earnings per Share

$8.71

Dividend per Share

$5.24

Valuation

Market Cap

658.00B

EBITDA

34.87B

Profit Margin

0.2148%

Dividend Yield

0.02%

Price / Sales (TTM)

6.650x

EPS Estimate (Current)

11.053

EPS Estimate (Next Year)

12.308

EV / Revenue

6.940x

EV / EBITDA

20.010x

Revenue Growth (YoY)

0.066%

Earnings Growth (YoY)

-0.009%

Share Statistics

Shares Outstanding

2.41B

Shares Float

2.41B

% Insiders

0.05%

% Institutions

76.91%

Shares Short

25.41M

Short Ratio

3.16

Short % of Float

0.01%

Float Ratio

99.84%

Normal (Float ≤ Outstanding)

Analyst Ratings
3.8
/ 5
Strong Sell
Strong Buy
Buy
Company Information

Address

One Johnson & Johnson Plaza
New Brunswick , NJ 08933
United States

Employees

138200

Officers

Dr. John C. Reed M.D., Ph.D.

Executive Vice President of Innovative Medicine and R&D

Born 1958

Mr. Dirk Brinckman

Chief Compliance Officer

Mr. James Swanson

Executive VP & Chief Information Officer

Born 1966

Mr. Joaquin Duato

CEO & Chairman

Born 1963

Mr. Joseph James Wolk CPA

Executive VP & CFO

Born 1967

Mr. Robert J. Decker Jr.

Controller & Chief Accounting Officer

Born 1973

Mr. Ryan Koors

Vice President of Investor Relations

Mr. Timothy Schmid

Executive VP & Worldwide Chairman of MedTech

Born 1970

Ms. Elizabeth Forminard J.D.

Executive VP & Chief Legal Officer

Born 1971

Ms. Kristen Blair Mulholland

Executive VP & Chief HR Officer

Born 1967

Calendar
Last Earnings

2026-07-15

BMO Period 2026-06-30
Act 2.90
Est 2.84
Surp 2.11%
Next Earnings

2026-10-13

BMO Period 2026-09-30
Act —
Est 3.05
Surp —
Earnings

Recent quarters & estimate trends

View full earnings (123)
Period EPS Act. EPS Est. Surprise
Sep 2026 — 2.95 —
Jun 2026 2.90 2.84 2.11%
Mar 2026 2.70 2.68 0.75%
Dec 2025 2.46 2.46 0.00%
Sep 2025 2.80 2.76 1.45%
Jun 2025 2.77 2.68 3.36%
Mar 2025 2.77 2.58 7.36%
Dec 2024 2.04 2.01 1.49%

Estimate trends

Dec 2027

12.31 EPS est.

11.0% growth

Dec 2026

11.05 EPS est.

2.0% growth

Sep 2026

2.43 EPS est.

-13.0% growth

Jun 2026

2.85 EPS est.

3.0% growth

Ownership

Top institutional & fund holders

View all holders (40)

Institutions

Holder Shares Chg %
BlackRock Inc 213.39M 2.21%
Vanguard Capital Management, LLC 156.61M 0.00%
State Street Corp 133.48M -0.29%
Vanguard Portfolio Management, LLC 63.51M 0.00%
JPMorgan Chase & Co 63.10M 7.75%

Funds

Holder Shares Chg %
Vanguard MStar Total Stk Mkt Idx Invest 76.65M 0.29%
Vanguard 500 Index Investor 63.19M 1.06%
iShares Core S&P 500 ETF 32.48M 0.16%
Fidelity 500 Index 30.88M 0.13%
State Street® SPDR® S&P 500® ETF 29.72M 0.08%